The Frederick County Office of Economic Development (FCOED) and Frederick Innovative Technology Center, Inc. (FITCI) have announced that
Cytomos, a biotech innovator based in the United Kingdom, has officially launched its U.S. expansion through the Maryland Global Gateway program.
The company established its U.S. operations in March in Frederick, Maryland, and welcomed Cailyn McNeil as its first Maryland-based team member to spearhead growth and engagement in the state.
“Cytomos’s decision to join the Global Gateway program underscores the strength of Frederick County’s biotech sector. The swift move to establish a presence here highlights the robust resources and support we offer to international companies looking to expand,” said County Executive Jessica Fitzwater. “We are proud to welcome Cytomos to Frederick County and look forward to seeing the company thrive in our community.”
“Maryland’s blend of technical talent, supportive biotech infrastructure, and access to U.S. research funding makes it the perfect launchpad for Cytomos’s expansion,” said David Rigterink, CEO of Cytomos. “The Maryland Global Gateway program offers a strategic framework that enables us to accelerate commercialization and collaboration. We’re excited to deepen our roots here and partner with organizations like FITCI to bring our novel gene therapy tools to the U.S. market.”
As part of their U.S. entry, Cytomos is also participating in FITCI’s Soft Landing Program, which provides international companies with mentoring, infrastructure, and resources to reduce barriers to U.S. market entry.
